197 related articles for article (PubMed ID: 35148403)
21. Presurgical predictors of early cognitive outcome after brain tumor resection in glioma patients.
Zangrossi A; Silvestri E; Bisio M; Bertoldo A; De Pellegrin S; Vallesi A; Della Puppa A; D'Avella D; Denaro L; Scienza R; Mondini S; Semenza C; Corbetta M
Neuroimage Clin; 2022; 36():103219. PubMed ID: 36209618
[TBL] [Abstract][Full Text] [Related]
22. Understanding cognitive functioning in glioma patients: The relevance of IDH-mutation status and functional connectivity.
Derks J; Kulik S; Wesseling P; Numan T; Hillebrand A; van Dellen E; de Witt Hamer PC; Geurts JJG; Reijneveld JC; Stam CJ; Klein M; Douw L
Brain Behav; 2019 Apr; 9(4):e01204. PubMed ID: 30809977
[TBL] [Abstract][Full Text] [Related]
23. A research of preoperative neurocognitive functioning and contributing factors in patients with supratentorial gliomas.
Wang L; Fang S; Peng Y
Neurosci Lett; 2022 Apr; 775():136527. PubMed ID: 35167943
[TBL] [Abstract][Full Text] [Related]
24. Correlation of immune phenotype with IDH mutation in diffuse glioma.
Berghoff AS; Kiesel B; Widhalm G; Wilhelm D; Rajky O; Kurscheid S; Kresl P; Wöhrer A; Marosi C; Hegi ME; Preusser M
Neuro Oncol; 2017 Oct; 19(11):1460-1468. PubMed ID: 28531337
[TBL] [Abstract][Full Text] [Related]
25. Functional-Based Resection Does Not Worsen Quality of Life in Patients with a Diffuse Low-Grade Glioma Involving Eloquent Brain Regions: A Prospective Cohort Study.
Muto J; Dezamis E; Rigaux-Viode O; Peeters S; Roux A; Zanello M; Mellerio C; Sauvageon X; Varlet P; Oppenheim C; Pallud J
World Neurosurg; 2018 May; 113():e200-e212. PubMed ID: 29432943
[TBL] [Abstract][Full Text] [Related]
26. Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma.
Derks J; Wesseling P; Carbo EWS; Hillebrand A; van Dellen E; de Witt Hamer PC; Klein M; Schenk GJ; Geurts JJG; Reijneveld JC; Douw L
J Neurooncol; 2018 Nov; 140(2):403-412. PubMed ID: 30094719
[TBL] [Abstract][Full Text] [Related]
27. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C
Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286
[TBL] [Abstract][Full Text] [Related]
28. Group-level stability but individual variability of neurocognitive status after awake resections of right frontal IDH-mutated glioma.
Barberis M; Poisson I; Facque V; Letrange S; Prevost-Tarabon C; Houdart E; Froelich S; Levy R; Mandonnet E
Sci Rep; 2022 Apr; 12(1):6126. PubMed ID: 35413966
[TBL] [Abstract][Full Text] [Related]
29. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
[TBL] [Abstract][Full Text] [Related]
30. Voxel-wise radiogenomic mapping of tumor location with key molecular alterations in patients with glioma.
Tejada Neyra MA; Neuberger U; Reinhardt A; Brugnara G; Bonekamp D; Sill M; Wick A; Jones DTW; Radbruch A; Unterberg A; Debus J; Heiland S; Schlemmer HP; Herold-Mende C; Pfister S; von Deimling A; Wick W; Capper D; Bendszus M; Kickingereder P
Neuro Oncol; 2018 Oct; 20(11):1517-1524. PubMed ID: 30107597
[TBL] [Abstract][Full Text] [Related]
31. Pre- and postoperative self-reported and objectively assessed neurocognitive functioning in lower grade glioma patients.
Pertz M; Kowalski T; Jetschke K; Schmieder K; Schlegel U; Miller D
J Clin Neurosci; 2022 Dec; 106():185-193. PubMed ID: 36369078
[TBL] [Abstract][Full Text] [Related]
32. Cognitive deficits in patients with low and high grade gliomas.
Raysi Dehcordi S; Mariano M; Mazza M; Galzio RJ
J Neurosurg Sci; 2013 Sep; 57(3):259-66. PubMed ID: 23877271
[TBL] [Abstract][Full Text] [Related]
33. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
[TBL] [Abstract][Full Text] [Related]
34. Genetic Modulation of Neurocognitive Function in Glioma Patients.
Liu Y; Zhou R; Sulman EP; Scheurer ME; Boehling N; Armstrong GN; Tsavachidis S; Liang FW; Etzel CJ; Conrad CA; Gilbert MR; Armstrong TS; Bondy ML; Wefel JS
Clin Cancer Res; 2015 Jul; 21(14):3340-6. PubMed ID: 25904748
[TBL] [Abstract][Full Text] [Related]
35. Assessment methods and prevalence of cognitive dysfunction in patients with low-grade glioma: A systematic review.
van Loon EM; Heijenbrok-Kal MH; van Loon WS; van den Bent MJ; Vincent AJ; de Koning I; Ribbers GM
J Rehabil Med; 2015 Jun; 47(6):481-8. PubMed ID: 25994416
[TBL] [Abstract][Full Text] [Related]
36. Multidomain and long-term cognitive evaluation in malignant glioma patients.
Tanzilli A; Pace A; Prosperini L; Oppido PA; Telera S; Rasile F; Farneti A; Marucci L; Villani V
Future Oncol; 2022 May; 18(15):1839-1848. PubMed ID: 35196869
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment patient-reported cognitive function in patients with diffuse glioma.
Schei S; Solheim O; Salvesen Ø; Hjermstad MJ; Bouget D; Sagberg LM
Acta Neurochir (Wien); 2022 Mar; 164(3):703-711. PubMed ID: 35142918
[TBL] [Abstract][Full Text] [Related]
38. Clinical and Biological Correlates of Preoperative Cognitive Functioning of Glioma and Meningioma Patients.
Pranckeviciene A; Deltuva VP; Tamasauskas A; Zegliene J; Bunevicius A
Biomed Res Int; 2020; 2020():2054859. PubMed ID: 32461966
[TBL] [Abstract][Full Text] [Related]
39. Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.
Vizcaino MA; Palsgrove DN; Yuan M; Giannini C; Cabrera-Aldana EE; Pallavajjala A; Burger PC; Rodriguez FJ
Brain Pathol; 2019 Mar; 29(2):193-204. PubMed ID: 30222900
[TBL] [Abstract][Full Text] [Related]
40. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
